Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model

Journal: Cancer Research

Published: 2021-01-20

DOI: 10.1158/0008-5472.can-20-1237

Affiliations: 28

Authors: 29

Go to article
Institutions Share
WHO International Agency for Research on Cancer (IARC), France 0.10
NIH National Cancer Institute (NCI), United States of America (USA) 0.10
Lunenfeld-Tanenbaum Research Institute (LTRI), U of T, Canada 0.07
North West Cancer Research Centre (NWCRC), University of Liverpool, United Kingdom (UK) 0.03
H. Lee Moffitt Cancer Center & Research Institute, United States of America (USA) 0.03
Cancer Cluster Salzburg (CCS), Austria 0.03
University Medical Center Göttingen (UMG), Germany 0.03
Vanderbilt University Medical Center (VUMC), United States of America (USA) 0.03
Markey Cancer Center (MCC), United States of America (USA) 0.03
Dartmouth College, United States of America (USA) 0.03
The University of British Columbia (UBC), Canada 0.03
National Institute of Occupational Health (STAMI), Norway 0.03
Washington State University (WSU), United States of America (USA) 0.03
Radboud University Medical Centre (Radboudumc), RU, Netherlands 0.03
Copenhagen University Hospital (CUH), Denmark 0.03
Fred Hutchinson Cancer Research Center (FHCRC), United States of America (USA) 0.03
University of Toronto (U of T), Canada 0.03
University of Hawaiʻi Cancer Center, United States of America (USA) 0.03
Princess Margaret Cancer Centre, U of T, Canada 0.03
Massachusetts General Hospital (MGH), United States of America (USA) 0.03
Johns Hopkins University (JHU), United States of America (USA) 0.03
Baylor College of Medicine (BCM), United States of America (USA) 0.03
Technion-Israel Institute of Technology (IIT), Israel 0.02
Carmel Medical Center, Israel 0.02
Biomedical Research Networking Center for Epidemiology and Public Health (CIBERESP), Spain 0.01
Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Spain 0.01
University of Oviedo (UniOvi), Spain 0.01

Return